Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Zhejiang Hisoar Pharmaceutical

In 2021, A-share ESG Information Disclosure Over 1,000 Listed Companies Concentrate on Green and Sustainable Development

  • Post date May 16, 2022 — 09:16 Post Lock Login to View

Read More

In 2021, A-Share ESG Information Disclosure Over 1,000 Listed Companies Concentrate on Green and Sustainable Development of ESGA Stock ESG Concept_Sina Technology_Sina Network

  • Post date May 16, 2022 — 09:15 Post Lock Login to View

Read More

On May 16th, 6 shares pre-market favorable announcement express CFi.CN Zhongcai Network

  • Post date May 16, 2022 — 09:05 Post Lock Login to View

Read More

A number of listed companies disclosed strategic cooperation plans

  • Post date May 16, 2022 — 04:35 Post Lock Login to View

Read More

On the evening of May 15th, Shanghai and Shenzhen listed companies announced the latest express of major events_ Oriental Fortune Net

  • Post date May 15, 2022 — 23:15 Post Lock Login to View

Read More

Promote product structure optimization and upgrade Haixiang Pharmaceutical signed a major strategic cooperation agreement

  • Post date May 15, 2022 — 23:01 Post Lock Login to View

Read More

Evening Announcements May 15 These announcements are worth seeing

  • Post date May 15, 2022 — 22:33 Post Lock Login to View

Read More

Evening Announcement Hotspot Tracking: The relocation of the Asian Cup will have a greater impact on ST Mingcheng – yqqlm

  • Post date May 15, 2022 — 21:42 Post Lock Login to View

Read More

Evening Announcements May 15 These announcements are worth seeing

  • Post date May 15, 2022 — 20:33 Post Lock Login to View

Read More

Listed company evening announcement express on May 15_Sina Finance_Sina.com

  • Post date May 15, 2022 — 20:21 Post Lock Login to View

Read More

Evening Announcements May 15 These announcements are worth seeing

  • Post date May 15, 2022 — 19:53 Post Lock Login to View

Read More

Featured Announcement: Zhongsheng Pharmaceutical's oral anti-coronavirus innovative drug RAY1216 was approved for clinical trial; Tongce Medical acquired 29.75% of Heren Technology

  • Post date May 15, 2022 — 19:45 Post Lock Login to View

Read More

On the evening of May 15th, Shanghai and Shenzhen listed companies announced the latest express of major events

  • Post date May 15, 2022 — 19:45 Post Lock Login to View

Read More

Highlights of the announcement on the evening of May 15: Tongce Medical's acquisition of 29.75% of Heren Technology will become the largest shareholder

  • Post date May 15, 2022 — 19:44 Post Lock Login to View

Read More

The latest announcement of Haixiang Pharmaceutical: Signing a strategic cooperation agreement with Xinkaiyuan_Stock News_Market Gold Online

  • Post date May 15, 2022 — 19:40 Post Lock Login to View

Read More

Haixiang Pharmaceutical and Xinkaiyuan signed a strategic cooperation agreement

  • Post date May 15, 2022 — 19:34 Post Lock Login to View

Read More

Haixiang Pharmaceutical (002099): Signing a Strategic Cooperation Agreement- CFi.CN China Finance Network

  • Post date May 15, 2022 — 17:46 Post Lock Login to View

Read More

Aoxiang Pharmaceutical's board secretary replied: Qizheng Pharmaceutical's related tablet production lines have not passed the GMP compliance inspection

  • Post date May 12, 2022 — 19:06 Post Lock Login to View

Read More

Haixiang Pharmaceutical: There is no cooperation between the company and Real Biology_Oriental Fortune Net

  • Post date May 12, 2022 — 11:23 Post Lock Login to View

Read More

Wansheng Co., Ltd. (603010): Zhejiang Wansheng Co., Ltd. 2021 Independent Director Debriefing Report- CFi.CN Zhongcai Network

  • Post date April 30, 2022 — 15:42 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.